Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Altria's $13B Juul investment has lost 95% of its value

Altria reports its nearly $13 billion investment in troubled vaping company Juul is worth 95% less than it originally paid

The Independent UK

Dems fear red states banning abortion will zero in on birth control next

Democrats fear that red, anti-abortion states could restrict or even ban birth control.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

What the heck is Pink Sauce and why should anyone not on TikTok care? Let us explain

You may have seen a “Pink Sauce” headline in your social feeds sometime in the past week. Maybe you skipped over it, but now it’s hard to escape. The Pink Sauce situation is real, and chef Carly Pii is taking it very, very personally.

Los Angeles Times

Federal bill to legalize marijuana would help, not hurt, the illicit market

California’s experience shows why burdensome taxes and regulations, as in Sen. Chuck Schumer’s proposed bill, would drive consumers away from the legal pot market.

Chicago Sun-Times

US to distribute 786,000 additional monkeypox vaccine doses obtained from Danish plant

Biden government has come under criticism for delayed response to monkeypox outbreak

The Independent UK

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193 in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of 130.58…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

EXCLUSIVE: SIGA Technologies CEO Says Company Is Prepared To Respond To Monkeypox Outbreak With TPOXX Stockpile Upon Approval

SIGA Technologies Inc (NASDAQ: SIGA) shares have rallied about 50% since the World Health Organization declared monkeypox a public health emergency of global concern.

Benzinga

We Don't Need a White House Monkeypox 'Coordinator.' We Just Need the Vaccines.

The feds botch another epidemic.

Reason

Medtronic Stock Keeps Ticking Forward

Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year. Medtronic is the world's largest medical device maker with a portfolio of glucose monitors, stents, insulin pumps, pacemakers, and catheters. It serves patients in over 150 countries.

Benzinga

Pink Sauce creator claims viral sauce doesn’t need FDA approval and the internet responds accordingly

“What do you mean FDA approved?” said the chef behind the mysterious Pink Sauce

The Independent UK

US signs off on 800,000 more doses of monkeypox vaccine

Health regulators say nearly 800,000 doses of monkeypox vaccine will soon be available for U.S. distribution

The Independent UK

FDA chief's long-promised opioid review faces skepticism

The head of the Food and Drug Administration says a comprehensive review of the opioid painkillers that triggered the nation's ongoing overdose epidemic is in the works

The Independent UK

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

The Conversation

Nature is the world's original pharmacy – returning to medicine's roots could help fill drug discovery gaps

While humans evolved over a period of approximately 6 million years, breakthroughs in modern medicine as we know it today got going only in the 19th and 20th centuries. So how did humans successfully survive through millions of years of diseases and illnesses without modern drugs and treatments?

Zenger

The Truth About Eating Ice Cream In The Summertime

In 1984, President Ronald Reagan declared the third Sunday of each July to be “National Ice Cream Day,” and it doesn’t seem like a coincidence that he picked a date in the middle of the hottest month in the United States, climatologically speaking, to commemorate a treat enjoyed by more…

Reason

Chuck Schumer Learned Nothing From the Failure of Pot Legalization in California

The Senate majority leader’s marijuana bill would pile on more taxes and regulations, despite years of complaints about the barriers they create.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Psychedelics And The National Institutes Of Health—How Do They Relate?

As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedel

Benzinga

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Inverse

Some people with epilepsy find relief with CBD — but the market is murky

The federal government has legalized cannabidiol (CBD). The FDA also has approved one cannabis-derived prescription drug, Epidiolex, for three rare seizure conditions.

Benzinga

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

WEKU

Reformulated COVID vaccine boosters may be available earlier than expected

The Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant.

Tribune News Service

Parents become drug developers to save their children’s lives

Maggie Carmichael wasn’t developing like other kids. As a toddler, she wasn’t walking and had a limited vocabulary for her age.

Benzinga

Why Ketamine-Assisted Psychotherapy May Be The New Vanguard Of SUD Treatment

By Peter Loeb, CEO of Lionrock

1 … 180 181 182 183

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.